CDKN2A and congenital rubella syndrome: Pairwise comparisons of CRS groups versus control showed that p16INK4a mRNA expression reduced significantly on days 3 (p = 0.031), 21 (p = 0.007), and 35 (p = 0.029; Figure 1A).